Aude Terrade
Overview
Explore the profile of Aude Terrade including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ndzomo P, Deghmane A, Tchatchouang S, Ngome R, Terrade A, Denizon M, et al.
J Infect
. 2025 Feb;
90(3):106448.
PMID: 39961439
Background: Haemophilus ducreyi, traditionally recognized as the etiological agent of chancroid, a genital ulcer disease, is increasingly being identified as a significant cause of cutaneous ulcers in yaws-endemic regions across...
2.
Taha S, Fantoni G, Hong E, Terrade A, Doucoure O, Deghmane A, et al.
Microorganisms
. 2025 Jan;
12(12.
PMID: 39770731
Most cases of invasive meningococcal disease (IMD) in Europe are caused by isolates of the serogroups B, C, W, and Y. We aimed to explore cases caused by other unusual...
3.
Denizon M, Hong E, Terrade A, Taha M, Deghmane A
Antibiotics (Basel)
. 2024 Aug;
13(8).
PMID: 39200061
Infections due to require prompt treatment using beta-lactam antibiotics. We used a collection of 81 isolates obtained between 1940 and 2001 from several countries. Whole genome sequencing showed the high...
4.
Taha S, Hong E, Denizon M, Falguieres M, Terrade A, Deghmane A, et al.
J Infect Public Health
. 2023 Oct;
16(12):1954-1960.
PMID: 37875044
Background: Invasive meningococcal disease (IMD) cases declined upon the implementation of non-pharmaceutical measures to control the COVID-19 pandemic. A rebound in IMD cases was feared upon easing these measures. Methods:...
5.
Robin C, Redjoul R, Terrade A, Deghmane A, Cabanne L, Cordonnier C, et al.
Clin Microbiol Infect
. 2022 Jul;
28(12):1609-1614.
PMID: 35803542
Objectives: Despite a high risk of invasive meningococcal (Men) disease, there is no published data on any MenB vaccine after hematopoietic cell transplantation (HCT). We investigated the immunogenicity and safety...
6.
Hong E, Terrade A, Muzzi A, De Paola R, Boccadifuoco G, La Gaetana R, et al.
Hum Vaccin Immunother
. 2021 Dec;
17(12):5614-5622.
PMID: 34856875
The 4CMenB, a protein-based vaccine, was licensed in Europe in 2013 against invasive meningococcal disease caused by serogroup B and is currently implemented in several countries although according to different...
7.
Hong E, Terrade A, Denizon M, Aouiti-Trabelsi M, Falguieres M, Taha M, et al.
BMC Infect Dis
. 2021 Jul;
21(1):715.
PMID: 34330228
Background: Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a...
8.
Tchatchouang S, Nzouankeu A, Hong E, Terrade A, Denizon M, Deghmane A, et al.
Int J Infect Dis
. 2020 Aug;
100:12-20.
PMID: 32827751
Objectives: To identifyHaemophilus species and characterize antimicrobial susceptibility of isolates from patients with respiratory tract infections (RTIs) in Cameroon. Methods: Isolates (n = 95) were from patients with RTIs obtained...
9.
Haddar C, Terrade A, Verhoeven P, Njanpop-Lafourcade B, Dosso M, Sidikou F, et al.
J Clin Microbiol
. 2020 Jan;
58(3).
PMID: 31915288
Meningococcal meningitis remains a life-threatening disease worldwide, with high prevalence in the sub-Saharan meningitis belt. A rapid diagnosis is crucial for implementing adapted antimicrobial treatment. We describe the performances of...
10.
Deghmane A, Hong E, Chehboub S, Terrade A, Falguieres M, Sort M, et al.
J Infect
. 2019 May;
79(1):7-14.
PMID: 31100360
Background: Invasive infections due to Haemophilus influenzae are infrequent following the implementation of vaccination against H. influenzae of serotype b. However, their changing epidemiology may not be clear due to...